THE PAN-INHIBITOR OF PIM KINASES, PIM447, POWER THE EFFECT OF POMALIDOMIDE AND DEXAMETASONE IN MULTIPLE MYELOMA

被引：0
|
作者：
Paino, T. [1 ]
San Segundo, L. [2 ]
Hernandez Garcia, S. [1 ]
Gonzalez Mendez, L. [2 ]
Algarin, E. M. [1 ]
Lopez Iglesias, A. A. [2 ]
Mogollon, P. [1 ]
Martin Sanchez, M. [2 ]
Diaz Tejedor, A. [1 ]
Gutierrez, N. [2 ]
Mateos, M. V. [1 ]
Garayoa, M. [2 ]
Ocio Enrique, M. [1 ]
机构：
[1] IBMCC, CIC, Salamanca, Spain
[2] Complejo Asistencial Univ Salamanca IBSAL, Salamanca, Spain
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP-003
引用
收藏
页码：3 / 4
页数：2
相关论文
共 48 条
  • [1] PRECLINIC EVALUATION OF PAN-INHIBITOR OF PIM-KINASAS, PIM447 IN THE BONE DISEASE ASSOCIATED WITH MULTIPLE MYELOMA
    Esperanza Macarena, Algarin
    Teresa, Paino
    Antonio, Garcia-Gomez
    Laura, San-Segundo
    Montserrat, Martin-Sanchez
    Susana, Hernandez-Garcia
    Ana Alicia, Lopez-Iglesias
    Lorena, Gonzalez-Mendez
    Enrique M, Ocio
    Mercedes, Garayoa
    [J]. HAEMATOLOGICA, 2016, 101 : 94 - 95
  • [2] Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
    Paino, Teresa
    Gonzalez-Mendez, Lorena
    San-Segundo, Laura
    Corchete, Luis A.
    Hernandez-Garcia, Susana
    Diaz-Tejedor, Andrea
    Algarin, Esperanza M.
    Mogollon, Pedro
    Martin-Sanchez, Montserrat
    Gutierrez, Norma C.
    Mateos, Maria-Victoria
    Garayoa, Mercedes
    Ocio, Enrique M.
    [J]. CANCERS, 2020, 12 (10) : 1 - 20
  • [3] THE PAN-PIM KINASE INHIBITOR, PIM447, POTENTLY SYNERGIZES WITH POMALIDOMIDE PLUS DEXAMETHASONE IN PRECLINICAL IN VITRO AND IN VIVO MODELS OF MULTIPLE MYELOMA
    Paino, T.
    San-Segundo, L.
    Hernandez-Garcia, S.
    Gonzalez-Mendez, L.
    Algarin, E. M.
    Martin-Sanchez, M.
    Mateos, M. -V.
    Garayoa, M.
    Ocio, E. M.
    [J]. HAEMATOLOGICA, 2017, 102 : 501 - 501
  • [4] The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
    Marc S. Raab
    Sheeba K. Thomas
    Enrique M. Ocio
    Andreas Guenther
    Yeow-Tee Goh
    Moshe Talpaz
    Nicolas Hohmann
    Sylvia Zhao
    Fang Xiang
    Carl Simon
    K. Gary Vanasse
    Shaji K. Kumar
    [J]. Leukemia, 2019, 33 : 2924 - 2933
  • [5] The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
    Raab, Marc S.
    Thomas, Sheeba K.
    Ocio, Enrique M.
    Guenther, Andreas
    Goh, Yeow-Tee
    Talpaz, Moshe
    Hohmann, Nicolas
    Zhao, Sylvia
    Xiang, Fang
    Simon, Carl
    Vanasse, K. Gary
    Kumar, Shaji K.
    [J]. LEUKEMIA, 2019, 33 (12) : 2924 - 2933
  • [6] The pan-PIM inhibitor PIM447 enhances the antitumor activity of lenalidomide in multiple myeloma cells via synergistic inhibition of c-MYC
    Hao, Huaixiang
    Wang, Dannie
    Vanasse, Gary
    Caponigro, Giordano
    [J]. CANCER RESEARCH, 2016, 76
  • [7] PIM Kinases in Multiple Myeloma
    Wu, Jian
    Chu, Emily
    Kang, Yubin
    [J]. CANCERS, 2021, 13 (17)
  • [8] Prognostic Implications of PIM-2 Expression in Samples from Patients with Chronic Lymphocytic Leukemia and Impact in the Sensitivity to the Pan-PIM Kinase Inhibitor PIM447
    Alicia Lopez-Iglesias, Ana
    Misiewicz-Krzeminska, Irena
    Criado, Ignacio
    Alcoceba, Miguel
    Hernandez-Garcia, Susana
    San-Segundo, Laura
    Gonzalez-Mendez, Lorena
    Martin-Sanchez, Montserrat
    Algarin, Esperanza M.
    Paino, Teresa
    Garayoa, Mercedes
    Gutierrez, Norma C.
    Mateos, Maria-Victoria
    Gonzalez-Diaz, Marcos
    Ocio, Enrique M.
    [J]. BLOOD, 2015, 126 (23)
  • [9] PIM Kinase Inhibitor, PIM447, Decreases Cancer Cell Stemness And Exhibits Synergy With Cisplatin In Hepatoblastoma
    Wadhwani, Nikita
    Marayati, Raoud
    Quinn, Colin H.
    Bownes, Laura V.
    Aye, Jamie M.
    Stewart, Jerry E.
    Yoon, Karina J.
    Beierle, Elizabeth A.
    [J]. PEDIATRICS, 2021, 147 (03)
  • [10] The Pan-PIM Kinase Inhibitor LGH447 Shows Activity In PIM2-Dependent Multiple Myeloma and In AML Models
    Garcia, Pablo D.
    Langowski, John L.
    Holash, Jocelyn
    Burger, Matthew
    Zang, Richard
    Zavorotinskaya, Tatiana
    Fanton, Christie
    Saci, Abdel
    Growney, Joseph
    Vanasse, K. Gary
    [J]. BLOOD, 2013, 122 (21)
12345